VJNeurology

LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke

Wearable technology in Parkinson's disease

The causes of brain fog

Update on current therapies for essential tremor

Predictors of conversion from positive to negative MOG antibody status

Clinical comparison of migraine with left- vs right-sided headache

Issues using EDSS to monitor treatment response in progressive MS

Recent developments in migraine treatment

Three-month outcomes for patients with chronic pain using cannabis-based medical products

INTERACT3 results: care bundle improves outcomes in intracerebral hemorrhage

ND0612 vs oral immediate-release levodopa/carbidopa in patients with PD and motor fluctuations

SECRET trial: rivaroxaban for cerebral venous thrombosis

Progressive MS: emerging treatments

Therapy apps for speech and language impairments after stroke

Review of BTK inhibition in MS

Novel brain penetrant capsids for Parkinson’s disease gene therapy

GFAP: a potential biomarker for progression in MS

LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke

Phase I study of selnoflast to slow neurodegeneration in Parkinson's disease

Upcoming trends and advances in headache treatment

What dictates MS progression: PIRA vs relapses

Recommended standards of care for adult patients with spinal muscular atrophy

Guillain-Barré syndrome and COVID-19 in Italy

Key questions for cell and gene therapy trials in Parkinson’s disease

Visual impairments in multiple sclerosis

Future of tau-targeting immunotherapies in Alzheimer’s disease

Predictors of early serologic diagnosis of AQ4-IgG positive NMOSD

Investigating long-COVID and chronic fatigue syndrome

Reperfusion therapy and post-stroke epilepsy risk

Treating spinal muscular atrophy in adult patients

Update on potential drugs targeting delta and kappa opioid receptors

Simultaneous comparison of 25 acute migraine medications: a big data analysis

Improving machine learning algorithms for seizure forecasting

The development of wearable devices for seizure forecasting

Using AI to predict epileptic seizures

Developments in seizure monitoring and forecasting tools

Understanding sex differences in neuroscience

EVT as a treatment for MeVO: current guidelines and new studies

REM sleep behavior disorder: an early indicator of Parkinson's disease

Upcoming developments in narcolepsy

REM sleep behavior disorder and its link to α-synucleinopathy

What is brain fog?

Phase III trials of tolebrutinib in relapsing-remitting and progressive MS

An overview of epileptogenicity after stroke

Current recommendations for blood pressure control in ischemic and hemorrhagic stroke

Pathophysiology of REM sleep behavior disorder

MND-SMART: the adaptive platform trial investigating potential treatments for MND

Anti-obesity drugs increase adult neurogenesis in the hypothalamus

The impact of diet and exercise on adult hippocampal neurogenesis

Interim data from ECST-2 trial challenges surgical guidelines for carotid stenosis

P2B001: a slow-release drug for Parkinson’s disease